Table 6.
Mean (SEM) percentage changes from baseline in Multiple Sclerosis Self-Efficacy Scale (MSSES) and Impact on Participation and Autonomy (IPA) scores at 1, 3 and 6 months after SCDP in PwMS with low disability (EDSS < 4.0) and high disability (EDSS > =4.0)
| |
1 month |
3 months |
6 months |
|||
|---|---|---|---|---|---|---|
| EDSS < 4.0 | EDSS > =4.0 | EDSS < 4.0 | EDSS > =4.0 | EDSS < 4.0 | EDSS > =4.0 | |
| MSSES-Function |
3.2% (1.9) |
5.4% (7.7) |
−2.7% (5.1) |
1.9% (9.6) |
2.5% (3.0) |
0.2% (9.5) |
| MSSES-Control |
6.5% (6.5) |
13.3% (10.4) |
5.8% (6.5) |
11.0% (16.6) |
23.8%* (8.1) |
22.9% (17.7) |
| IPA-Limitations |
−6.3% (3.9) |
−2.0% (3.0) |
−6.1%** (3.0) |
−0.6% (4.3) |
−4.8% (4.0) |
−1.3% (4.0) |
| IPA-Problems | −4.2% (4.2) | −2.9% (3.1) | −8.8%** (4.3) | −3.7% (4.0) | −1.3% (5.3) | −3.1% (4.1) |
*, P < 0.01; **, 0.05 < P < 0.06 (comparisons with baseline).